High-dose chemotherapy with subsequent autologous stem cell transplantation in children and adolescents for high-risk rhabdomyosarcoma. A 3-year survival outcome;Vysokodavkovana terapie s naslednou autologni transplantaci hematopoetickych kmenovych bunek u deti a mladistvych s rabdomyosarkomem vysokeho rizika. Vysledky trileteho prezivani

Klinicka Onkologie

Volumn 10, Issue 5, 1997, Pages 148-151

  Kavan, P ^a   Stankova, J ^a   Koutecky, J ^a   Gajdos, P ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Autologous bone marrow transplantation; Megatherapy; Rhabdomyosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; VINCRISTINE;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0031445944     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)